Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Melissa D. Johnson, PharmD, MHS, AAHIVP
Infectious Disease
July 18, 2023 Evan Vega

How are ID pharmacists dealing with burnout?

Source/Disclosures Published by: sources: Healio Interviews Disclosures: Johnson reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an

Read More
Public Health
July 18, 2023 Evan Vega

Timeline: The Final Years of the Campaign to End Smallpox

Many people working in global health thought eradicating smallpox was impossible. They were wrong. Season 2 of the Epidemic podcast,

Read More
IDC0123Triomphe_Graphic_01
Infectious Disease
July 18, 2023 Evan Vega

FDA approves monoclonal antibody to prevent RSV in infants

ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to

Read More
Alzheimer's drug donanemab shows positive results, Eli Lilly asks for approval
Public Health
July 18, 2023 Evan Vega

Alzheimer’s drug donanemab shows positive results, Eli Lilly asks for approval

Eli Lilly on Monday said it applied for full US Food and Drug Administration approval of its Alzheimer’s treatment, donanemab,

Read More
Nurse-led allergy clinics expand access to care, improve patient satisfaction
Infectious Disease
July 17, 2023 Evan Vega

27.6% of kids missed or delayed preventive care during COVID-19 pandemic

Source/Disclosures Disclosures: Tabet reports no relevant financial disclosures. Please see the study for all authors’ relevant financial disclosures. ADD TOPIC

Read More
Public Health
July 17, 2023 Evan Vega

Readers and Tweeters See Ways to Shore Up Primary Care

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity

Read More
PC0723Day_Graphic_01_WEB
Infectious Disease
July 17, 2023 Evan Vega

23-valent pneumococcal vaccine linked to necrosis, but risks do not outweigh benefits

ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to

Read More
Public Health
July 17, 2023 Evan Vega

In Older Adults, a Little Excess Weight Isn’t Such a Bad Thing

Millions of people enter later life carrying an extra 10 to 15 pounds, weight they’ve gained after having children, developing

Read More
Obesity drug maker Versanis to be bought by Eli Lilly
Public Health
July 17, 2023 Evan Vega

Obesity drug maker Versanis to be bought by Eli Lilly

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | covers | Getty Images Eli Lilly

Read More
IDN0723Faust_Graphic_01
Infectious Disease
July 17, 2023 Evan Vega

Among younger adults, Paxlovid shows benefits for some but not others

Source/Disclosures Published by: sources: Faust JS, et al. Clin Infect Dis. 2023;doi:10.1093/cid/ciad400. Disclosures: The authors report no relevant financial disclosures.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.